Publications
 

Genetics of solid tumors

Florence PEDEUTOUR, Professor-Clinician, PU-PH1
 
  • Superficial CD34-positive Fibroblastic Tumour: Unique Subungual Presentation with Confounding Clinical Findings Resembling Fibrokeratoma-like Bowen's Disease

    Perrin C, Pedeutour F, Dadone-Montaudié B, Ambrosetti D.

    Acta Derm Venereol. 2020 Dec 15

    doi: 10.2340/00015555-3727

    PMID: 33320273

  • MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction

    Di Mauro I, Mescam-Mancini L, Chetaille B, Lae M, Pierron G, Dadone-Montaudie B, Bazin A, Bouvier C, Michiels JF, Pedeutour F.

    Neoplasia. 2020 Aug;22(8):311-321

    doi: 10.1016/j.neo.2020.05.003. Epub 2020 Jun 16

    PMID: 32559641

  • A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas

    Burel-Vandenbos F, Pierron G, Thomas C, Reynaud S, Gregoire V, Duhil de Benaze G, Croze S, Chivoret N, Honavar M, Figarella-Branger D, Maurage CA, Pedeutour F, Hasselblatt M, Godfraind C.

    Neuropathol Appl Neurobiol. 2020 Aug;46(5):506-509

    doi: 10.1111/nan.12626. Epub 2020 Jun 3

    PMID: 32397004

  • Intracranial chondromas: A histopathologic and molecular study of three cases

    Tauziède-Espariat A, Burel-Vandenbos F, Pedeutour F, Gareton A, Saffroy R, Andreiuolo F, Blauwblomme T, Dangouloff-Ros V, Boddaert N, Lechapt E, Chrétien F, Varlet P.

    Clin Neuropathol. 2020 Jul/Aug;39(4):171-178

    doi: 10.5414/NP301238

    PMID: 31983386

  • Detection of tetraploidization in chromophobe renal cell carcinoma: Insights and pitfalls

    Di Mauro I, Ambrosetti D, Vignot L, Roussel JF, Dadone-Montaudie B, Peyron AC, Quintens H, Durand M, Amiel J, Pedeutour F.

    Genes Chromosomes Cancer. 2020 Jul 13

    doi: 10.1002/gcc.22886

    PMID: 32658344

  • Soft tissue angiomatosis: another PIK3CA-related disorder

    Boccara O, Galmiche-Rolland L, Dadone-Montaudié B, Ariche-Maman S, Coulet F, Eyries M, Pannier S, Soupre V, Molina T, Pedeutour F, Fraitag S.

    Histopathology. 2020 Mar;76(4):540-549

    doi: 10.1111/his.14021. Epub 2020 Jan 24

    PMID: 31630434

  • ERK mediated loss of miR-199a-3p and induction of EGR1 act as a “toggle switch” of GBM cell dedifferentiation into NANOG- and OCT4- positive cells

    Almairac F, Turchi L, Sakakini N, Debruyne DN, Elkeurti S, Gjernes E, Polo B, Bianchini L, Fontaine D, Paquis P, Chneiweiss H, Junier M-P, Verrando P, Burel-Vandenbos F and Virolle T.

    Cancer Res 2020, 80: 3236-3250.

    doi: 10.1158/0008-5472.CAN-19-0855

    PMID: 32366479

  • Novel therapeutic insights in dedifferentiated liposarcoma: a role for FGFR and MDM2 dual targeting

    Dadone-Montaudié B, Laroche-Clary A, Mongis A, Chamorey E, Di Mauro I, Chaire V, Finetti P, Schiappa R, Le Loarer F, Birtwisle-Peyrottes I, Michiels J-F, Bertucci F, Pedeutour F, Italiano A, Bianchini L.

    Cancers 2020, 12: 3058

    doi: 10.3390/cancers12103058

    PMID: 33092134

  • High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies

    Toulmonde M, Lucchesi C, Verbeke S, Crombe A, Adam J, Geneste D, Chaire V, Laroche-Clary A, , Perret R, Bertucci F,  Bertolo F, Bianchini L, Dadone-Montaudié B, Hembrough T, Sweet S, Kim YJ, Cecchi F, Le Loarer F, Italiano A.

    EBioMedicine 62, 2020.

    doi: 10.1016/j.ebiom.2020.103131

    PMID: 33254023

  • A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans

    Delyon J, Porcher R, Battistella M, Meyer N, Adamski H, Bertucci F, Guillot B, Jouary T, Leccia MT, Dalac S, Mortier L, Ghrieb Z, Da Meda L, Vicaut E, Pedeutour F, Mourah S, Lebbe C.

    J Invest Dermatol. 2020 Sep 18:S0022-202X(20)32067-4

    doi: 10.1016/j.jid.2020.06.039

    PMID: 32956651

  • Cellular Angiofibroma: Case Report of a Unique Subungual Presentation

    Perrin C, Cannata GE, Pedeutour F, Dadone-Montaudié B, Ambrosetti D.

    Acta Derm Venereol. 2019 Sep 1;99(10):915-916.

    doi: 10.2340/00015555-3152

    PMID: 30809688

  • Double minute chromosomes harboring MDM2 amplification in a pediatric atypical lipomatous tumor.

    Dadone-Montaudié B, Burel-Vandenbos F, Soler C, Rosello O, Boyer C, Fabas T, Bianchini L, Pedeutour F.

    Genes Chromosomes Cancer, 2019, 58:673-679.

    doi: 10.1002/gcc.22754

    PMID: 30887579

  • The Hidden Genomic and Transcriptomic Plasticity of Giant Marker Chromosomes in Cancer.

    Macchia G, Severgnini M, Purgato S, Tolomeo D, Casciaro H, Cifola I, L'Abbate A, Loverro A, Palumbo O, Carella M, Bianchini L, Perini G, De Bellis G, Mertens F, Rocchi M, Storlazzi CT.

    Genetics. 2018 Mar;208(3):951-961. doi: 10.1534/genetics.117.300552. Epub 2017 Dec 26.

    PMID: 29279323
  • DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.

    Debruyne DN, Turchi L, Burel-Vandenbos F, Fareh M, Almairac F, Virolle V, Figarella-Branger D, Baeza-Kallee N, Lagadec P, Kubiniek V, Paquis P, Fontaine D, Junier MP, Chneiweiss H, Virolle T.

    Oncogene. 2018 Jan 11;37(2):241-254. doi: 10.1038/onc.2017.323. Epub 2017 Sep 18.

    PMID: 28925399
  • ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review.

    Bodokh Y, Ambrosetti D, Kubiniek V, Tibi B, Durand M, Amiel J, Pertuit M, Barlier A, Pedeutour F.

    Cancer Genet. 2018 Feb;221:31-37. doi: 10.1016/j.cancergen.2017.11.010. Epub 2017 Dec 12. Review.

    PMID: 29405994
  • Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.

    Dadone-Montaudié B, Alberti L, Duc A, Delespaul L, Lesluyes T, Pérot G, Lançon A, Paindavoine S, Di Mauro I, Blay JY, de la Fouchardière A, Chibon F, Karanian M, MacGrogan G, Kubiniek V, Keslair F, Cardot-Leccia N, Michot A, Perrin V, Zekri Y, Coindre JM, Tirode F, Pedeutour F, Ranchère-Vince D, Le Loarer F, Pissaloux D.

    Mod Pathol. 2018 Nov;31(11):1683-1693. doi: 10.1038/s41379-018-0089-4. Epub 2018 Jun 28.

    PMID: 29955147
  • Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome.

    Mendel L, Ambrosetti D, Bodokh Y, Ngo-Mai M, Durand M, Simbsler-Michel C, Delhorbe M, Amiel J, Pedeutour F.

    Genes Chromosomes Cancer. 2018 Mar;57(3):99-113. doi: 10.1002/gcc.22513. Epub 2017 Dec 20. Review.

    PMID: 29127730
  • Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinoma.

    Tardy MP, Di Mauro I, Ebran N, Refae S, Bozec A, Benezery K, Peyrade F, Guigay J, Sudaka-Bahadoran A, Badoual C, Pedeutour F, Saada-Bouzid E.

    Oral Oncol. 2018 May;80:104-107. doi: 10.1016/j.oraloncology.2018.04.001. Epub 2018 Apr 7. No abstract available.

    PMID: 29631799
  • The hidden genomic and transcriptomic plasticity of giant marker chromosomes in cancer

    Macchia G, Severgnini M, Purgato S, Tolomeo D, Casciaro H, Cifola I, L’Abbate A, Loverro A, Palumbo O, Carella M, Bianchini L, Perini G, De Bellis G, Mertens F, Rocchi M, Storlazzi CT.

    Genetics, 2018, 208: 951-961.

    doi: 10.1534/genetics.117.300552

    PMID: 29279323

  • Meningeal SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily B member 1 (SMARCB1)-deficient tumours: an emerging group of meningeal tumours.

    Dadone B, Fontaine D, Mondot L, Cristofari G, Jouvet A, Godfraind C, Varlet P, Ranchère-Vince D, Coindre JM, Gastaud L, Baudoin C, Peyron AC, Thyss A, Coutts M, Michiels JF, Pedeutour F, Burel-Vandenbos F; RENOP.

    Neuropathol Appl Neurobiol. 2017 Aug;43(5):433-449. doi: 10.1111/nan.12364. Epub 2016 Dec 28.

    PMID: 27732747
  • Detection of RAS genes mutation using the Cobas(®) method in a private laboratory of pathology: Medical and economical study in comparison to a public platform of molecular biology of cancer

    Albertini AF, Raoux D, Neumann F, Rossat S, Tabet F, Pedeutour F, Duranton-Tanneur V, Kubiniek V, Vire O, Weinbreck N.

    Bull Cancer. 2017 Jul - Aug;104(7-8):662-674. doi: 10.1016/j.bulcan.2017.05.005. Epub 2017 Jul 5. French.

    PMID: 28688743
  • Congenital Infantile Fibrosarcoma Associated With a Lipofibromatosis-Like Component: One Train May Be Hiding Another.

    Swiadkiewicz R, Galmiche L, Belhous K, Boccara O, Fraitag S, Pedeutour F, Dadone B, Buis J, Picard A, Orbach D, Kadlub N.

    Am J Dermatopathol. 2017 Jun;39(6):463-467. doi: 10.1097/DAD.0000000000000696.

    PMID: 28525423
  • PDGFRa amplification in multiple skin lesions of undifferentiated pleomorphic sarcoma: A clue for intimal sarcoma metastases.

    Osio A, Vignon-Pennamen MD, Pedeutour F, Le Maignan C, Koskas F, Lebbé C, Janin A, Battistella M.

    J Cutan Pathol. 2017 May;44(5):477-479. doi: 10.1111/cup.12907. Epub 2017 Feb 15.

    PMID: 28105789
  • Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab.

    Picard A, Pedeutour F, Peyrade F, Saudes L, Duranton-Tanneur V, Chamorey E, Cardot-Leccia N, Sudaka A, Ettaiche M, Benchetrit M, Poissonnet G, Weinbreck N, Dadone B, Lacour JP, Passeron T, Montaudié H.

    JAMA Dermatol. 2017 Apr 1;153(4):291-298. doi: 10.1001/jamadermatol.2017.0270.

    PMID: 28259104
  • MET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma.

    Burel-Vandenbos F, Ngo-Mai M, Dadone B, Di Mauro I, Gimet S, Saada-Bouzid E, Bourg V, Almairac F, Fontaine D, Virolle T, Pedeutour F.

    Neuropathol Appl Neurobiol. 2017 Apr;43(3):252-266. doi: 10.1111/nan.12320. Epub 2016 Apr 4.

    PMID: 26946354
  • Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes.

    Massalou D, Benizri E, Chevallier A, Duranton-Tanneur V, Pedeutour F, Benchimol D, Béréder JM.

    Am J Surg. 2017 Feb;213(2):377-387. doi: 10.1016/j.amjsurg.2016.03.008. Epub 2016 Aug 5.

    PMID: 27816197
  • Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment.

    Lhermitte B, Egele C, Weingertner N, Ambrosetti D, Dadone B, Kubiniek V, Burel-Vandenbos F, Coyne J, Michiels JF, Chenard MP, Rouleau E, Sabourin JC, Bellocq JP.

    Virchows Arch. 2017 Jan;470(1):21-27. doi: 10.1007/s00428-016-2042-6. Epub 2016 Nov 16.

    PMID: 27853865
  • Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: evidence for a specific entity with poor outcome

    Mendel L, Ambrosetti D, Bodokh Y, Ngo-Mai M, Durand M, Simbsler-Michel C, Delhorbe M, Amiel J, Pedeutour F.

    Genes Chromosomes Cancer. 2017 Nov 11. 

    PMID: 29127730
  • Challenging a dogma: co-mutations exist in MAPK pathway genes in colorectal cancer.

    Grellety T, Gros A, Pedeutour F, Merlio JP, Duranton-Tanneur V, Italiano A, Soubeyran I.

    Virchows Arch. 2016 Oct;469(4):459-64. doi: 10.1007/s00428-016-1991-0. Epub 2016 Jul 11.

    PMID: 27401719
  • Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.

    Italiano A, Di Mauro I, Rapp J, Pierron G, Auger N, Alberti L, Chibon F, Escande F, Voegeli AC, Ghnassia JP, Keslair F, Laé M, Ranchère-Vince D, Terrier P, Baffert S, Coindre JM, Pedeutour F.

    Lancet Oncol. 2016 Apr;17(4):532-538. doi: 10.1016/S1470-2045(15)00583-5. Epub 2016 Mar 10.

    PMID: 26970672
  • MET immunolabeling is a useful predictive tool for MET gene amplification in glioblastoma.

    Burel-Vandenbos F, Ngo-Mai M, Dadone B, Di Mauro I, Gimet S, Saada-Bouzid E, Bourg V, Almairac F, Fontaine D, Virolle T, Pedeutour F.

    Neuropathol Appl Neurobiol. 2017 Apr;43(3):252-266. doi: 10.1111/nan.12320. Epub 2016 Apr 4.

    PMID: 26946354
  • Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer.

    Dequeker EM, Keppens C, Egele C, Delen S, Lamy A, Lemoine A, Sabourin JC, Andrieu C, Ligtenberg M, Fetique D, Tops B, Descarpentries C, Blons H, Denoux Y, Aube C, Penault-Llorca F, Hofman P, Leroy K, Le Marechal C, Doucet L, Duranton-Tanneur V, Pedeutour F, Soubeyran I, Côté JF, Emile JF, Vignaud JM, Monhoven N, Haddad V, Laurent-Puig P, van Krieken H, Nowak F, Lonchamp E, Bellocq JP, Rouleau E.

    J Mol Diagn. 2016 Mar;18(2):205-14. doi: 10.1016/j.jmoldx.2015.09.004. Epub 2016 Jan 2.

    PMID: 26752307
  • HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.

    Angelika Ihle M, Merkelbach-Bruse S, Hartmann W, Bauer S, Ratner N, Sonobe H, Nishio J, Larsson O, Åman P, Pedeutour F, Taguchi T, Wardelmann E, Buettner R, Schildhaus HU.

    J Pathol Clin Res. 2016 Feb 5;2(2):59-71. doi: 10.1002/cjp2.35. eCollection 2016 Apr.

    PMID: 27499916
  • Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.

    Marsaud A, Dadone B, Ambrosetti D, Baudoin C, Chamorey E, Rouleau E, Lefol C, Roussel JF, Fabas T, Cristofari G, Carpentier X, Michiels JF, Amiel J, Pedeutour F.

    Genes Chromosomes Cancer. 2015 Jun;54(6):369-82. doi: 10.1002/gcc.22248. Epub 2015 Mar 28.

    PMID: 25820192
  • SRC inhibition represents a potential therapeutic strategy in liposarcoma.

    Sievers E, Trautmann M, Kindler D, Huss S, Gruenewald I, Dirksen U, Renner M, Mechtersheimer G, Pedeutour F, Åman P, Nishio J, Schildhaus HU, Kirfel J, Schirmacher P, Wardelmann E, Buettner R, Hartmann W.

    Int J Cancer. 2015 Dec 1;137(11):2578-88. doi: 10.1002/ijc.29645. Epub 2015 Jul 6.

    PMID: 26084847
  • Molecular cytogenetics of pediatric adipocytic tumors.

    Dadone B, Refae S, Lemarié-Delaunay C, Bianchini L, Pedeutour F.

    Cancer Genet. 2015 Oct;208(10):469-81. doi: 10.1016/j.cancergen.2015.06.005. Epub 2015 Jun 26. Review.

    PMID: 26319758
  • Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.

    Saâda-Bouzid E, Burel-Vandenbos F, Ranchère-Vince D, Birtwisle-Peyrottes I, Chetaille B, Bouvier C, Château MC, Peoc'h M, Battistella M, Bazin A, Gal J, Michiels JF, Coindre JM, Pedeutour F, Bianchini L.

    Mod Pathol. 2015 Nov;28(11):1404-14. doi: 10.1038/modpathol.2015.96. Epub 2015 Sep 4.

    PMID: 26336885
  • Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions.

    Doyen J, Duranton-Tanneur V, Hostein I, Karanian-Philippe M, Chevreau C, Breibach F, Coutts M, Dadone B, Saint-Paul MC, Gugenheim J, Duffaud F, Pedeutour F.

    Virchows Arch. 2016 Mar;468(3):369-74. doi: 10.1007/s00428-015-1883-8. Epub 2015 Dec 14.

    PMID: 26666421
  • Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans.

    Karanian M, Pérot G, Coindre JM, Chibon F, Pedeutour F, Neuville A.

    Mod Pathol. 2015 Feb;28(2):230-7. doi: 10.1038/modpathol.2014.97. Epub 2014 Aug 1.

    PMID: 25081750
  • Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.

    Zaragosi LE, Dadone B, Michiels JF, Marty M, Pedeutour F, Dani C, Bianchini L.

    Carcinogenesis. 2015 Jan;36(1):32-40. doi: 10.1093/carcin/bgu222. Epub 2014 Oct 24.

    PMID: 25344834
  • Angiomatoid fibrous histiocytoma in children: 6 cases

    Bohelay G, Kluger N, Battistella M, Biaggi-Frassati A, Plantier F, Harraudeau A, Avril MF, Pedeutour F, Fraitag S.

    Ann Dermatol Venereol. 2015 Oct;142(10):541-8. doi: 10.1016/j.annder.2015.07.007. Epub 2015 Sep 9. Review. French.

    PMID: 26363999
  • The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.

    Grépin R, Ambrosetti D, Marsaud A, Gastaud L, Amiel J, Pedeutour F, Pagès G.

    PLoS One. 2014 Mar 27;9(3):e89449. doi: 10.1371/journal.pone.0089449. eCollection 2014.

    PMID: 24676409
  • The architecture and evolution of cancer neochromosomes.

    Garsed DW, Marshall OJ, Corbin VD, Hsu A, Di Stefano L, Schröder J, Li J, Feng ZP, Kim BW, Kowarsky M, Lansdell B, Brookwell R, Myklebost O, Meza-Zepeda L, Holloway AJ, Pedeutour F, Choo KH, Damore MA, Deans AJ, Papenfuss AT, Thomas DM.

    Cancer Cell. 2014 Nov 10;26(5):653-67. doi: 10.1016/j.ccell.2014.09.010. Epub 2014 Nov 10.

    PMID: 25517748
  • Identification of PPAP2B as a novel recurrent translocation partner gene of HMGA2 in lipomas.

    Bianchini L, Birtwisle L, Saâda E, Bazin A, Long E, Roussel JF, Michiels JF, Forest F, Dani C, Myklebost O, Birtwisle-Peyrottes I, Pedeutour F.

    Genes Chromosomes Cancer. 2013 Jun;52(6):580-90. doi: 10.1002/gcc.22055. Epub 2013 Mar 18.

    PMID: 23508853
  • Comprehensive genome characterization of solitary fibrous tumors using high-resolution array-based comparative genomic hybridization.

    Bertucci F, Bouvier-Labit C, Finetti P, Adélaïde J, Metellus P, Mokhtari K, Decouvelaere AV, Miquel C, Jouvet A, Figarella-Branger D, Pedeutour F, Chaffanet M, Birnbaum D.

    Genes Chromosomes Cancer. 2013 Feb;52(2):156-64. doi: 10.1002/gcc.22015. Epub 2012 Oct 17.

    PMID: 23073997
  • Performance and cost efficiency of KRAS mutation testing for metastatic colorectal cancer in routine diagnosis: the MOKAECM study, a nationwide experience.

    Blons H, Rouleau E, Charrier N, Chatellier G, Côté JF, Pages JC, de Fraipont F, Boyer JC, Merlio JP, Morel A, Gorisse MC, de Cremoux P, Leroy K, Milano G, Ouafik L, Merlin JL, Le Corre D, Aucouturier P, Sabourin JC, Nowak F, Frebourg T, Emile JF, Durand-Zaleski I, Laurent-Puig P; MOKAECM Collaborative Group.

    PLoS One. 2013 Jul 25;8(7):e68945. doi: 10.1371/journal.pone.0068945. Print 2013.

    PMID: 23935912
  • Immunohistological features in adenomatoid odontogenic tumor: review of the literature and first expression and mutational analysis of β-catenin in this unusual lesion of the jaws.

    Harnet JC, Pedeutour F, Raybaud H, Ambrosetti D, Fabas T, Lombardi T.

    J Oral Maxillofac Surg. 2013 Apr;71(4):706-13. doi: 10.1016/j.joms.2012.10.006. Epub 2012 Dec 20. Review.

    PMID: 23265580
  • EGFR mutation status in brain metastases of non-small cell lung carcinoma.

    Burel-Vandenbos F, Ambrosetti D, Coutts M, Pedeutour F.

    J Neurooncol. 2013 Jan;111(1):1-10. doi: 10.1007/s11060-012-0990-5. Epub 2012 Oct 20. Review.

    PMID: 23086434
  • Autophagy plays a critical role in the degradation of active RHOA, the control of cell cytokinesis, and genomic stability.

    Belaid A, Cerezo M, Chargui A, Corcelle-Termeau E, Pedeutour F, Giuliano S, Ilie M, Rubera I, Tauc M, Barale S, Bertolotto C, Brest P, Vouret-Craviari V, Klionsky DJ, Carle GF, Hofman P, Mograbi B.

    Cancer Res. 2013 Jul 15;73(14):4311-22. doi: 10.1158/0008-5472.CAN-12-4142. Epub 2013 May 23.

    PMID: 23704209
  • Conservative multimodal management of a primitive neuroectodermal tumor of the thyroid.

    Natale R, Thariat J, Vedrine PO, Bozec A, Peyrottes I, Marcy PY, Haudebourg J, Pedeutour F, Saâda E, Thyss A.

    Rare Tumors. 2013 May 29;5(2):75-8. doi: 10.4081/rt.2013.e20. Print 2013 Apr 15.

    PMID: 23888220
  • EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients.

    Villalva C, Duranton-Tanneur V, Guilloteau K, Burel-Vandenbos F, Wager M, Doyen J, Levillain PM, Fontaine D, Blons H, Pedeutour F, Karayan-Tapon L.

    Cancer Med. 2013 Jun;2(3):296-304. doi: 10.1002/cam4.82. Epub 2013 Apr 23.

    PMID: 23930206
  • Comparative cost analysis of molecular biology methods in the diagnosis of sarcomas.

    Baffert S, Italiano A, Pierron G, Traoré MA, Rapp J, Escande F, Ghnassia JP, Terrier P, Voegeli AC, Ranchere-Vince D, Coindre JM, Pedeutour F.

    Bull Cancer. 2013 Oct;100(10):963-71. doi: 10.1684/bdc.2013.1822. French.

    PMID: 24095719
  • Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group.

    Emile JF, Tisserand J, Bergougnoux L, Nowak F, Faucher G, Surel S, Lamy A, Lecorre D, Helias-Rodzewicz Z, Hofman P, Sabourin JC, Laurent-Puig P; BRAF EQA Group.

    BMC Cancer. 2013 Oct 11;13:472. doi: 10.1186/1471-2407-13-472.

    PMID: 24119386
  • A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?

    Dadone B, Ambrosetti D, Carpentier X, Duranton-Tanneur V, Burel-Vandenbos F, Amiel J, Pedeutour F.

    Cancer Genet. 2013 Sep-Oct;206(9-10):347-52.

    PMID: 24432405
  • Renal cell carcinoma and a constitutional t(11;22)(q23;q11.2): case report and review of the potential link between the constitutional t(11;22) and cancer.

    Doyen J, Carpentier X, Haudebourg J, Hoch B, Karmous-Benailly H, Ambrosetti D, Fabas T, Amiel J, Lambert JC, Pedeutour F.

    Cancer Genet. 2012 Nov;205(11):603-7. doi: 10.1016/j.cancergen.2012.09.006. Epub 2012 Oct 30.

    PMID: 23117075
  • SMARCB1/INI1 inactivation in renal medullary carcinoma.

    Calderaro J, Moroch J, Pierron G, Pedeutour F, Grison C, Maillé P, Soyeux P, de la Taille A, Couturier J, Vieillefond A, Rousselet MC, Delattre O, Allory Y.

    Histopathology. 2012 Sep;61(3):428-35. doi: 10.1111/j.1365-2559.2012.04228.x. Epub 2012 Jun 11.

    PMID: 22686875
  • A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions.

    Pedeutour F, Maire G, Pierron A, Thomas DM, Garsed DW, Bianchini L, Duranton-Tanneur V, Cortes-Maurel A, Italiano A, Squire JA, Coindre JM.

    Virchows Arch. 2012 Jul;461(1):67-78. doi: 10.1007/s00428-012-1256-5. Epub 2012 Jun 8.

    PMID: 22678079
  • First description of inhibition of let-7 microRNA expression and HMGA2 overexpression in a case of deep-seated diffuse lipomatosis.

    Saâda E, Bianchini L, Mouroux J, Dupré F, Butori C, Birtwisle-Peyrottes I, Padovani B, Yver M, Ferrari C, Pedeutour F.

    Histopathology. 2012 Sep;61(3):519-22. doi: 10.1111/j.1365-2559.2012.04266.x. Epub 2012 May 29. No abstract available.

    PMID: 22642449
  • Rearrangement of HMGA2 in a case of infantile lipoblastoma without PLAG1 alteration.

    Pedeutour F, Deville A, Steyaert H, Ranchere-Vince D, Ambrosetti D, Sirvent N.

    Pediatr Blood Cancer. 2012 May;58(5):798-800. doi: 10.1002/pbc.23335. Epub 2012 Jan 6.

    PMID: 22223189
  • Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.

    Darini CY, Pisani DF, Hofman P, Pedeutour F, Sudaka I, Chomienne C, Dani C, Ladoux A.

    Oncogene. 2012 May 10;31(19):2438-49. doi: 10.1038/onc.2011.421. Epub 2011 Sep 19.

    PMID: 21927026
Research teams